Question: Is there enough medical supplies for people with Tuberculosis and people with COVID 19?

Answer passage (source: WHO):
page_title: Q&A: Tuberculosis and COVID-19
section_headers: How can health authorities ensure supplies of tuberculosis medicines and diagnostics?
section_content: Appropriate planning and monitoring are essential to ensure that procurement
and supply of tuberculosis (TB) medicines and diagnostics are not interrupted.  
WHO is monitoring medicine supply at the global level, while The Global Fund,
the Stop TB Partnership Global Drug Facility (GDF), USAID, Unitaid and other
donors play an essential role in supporting countries to secure adequate and
sustainable supplies of TB medicines, drugs and diagnostics.
Countries are advised to place their orders for 2020 delivery as soon as
possible given anticipated delays in transport and delivery mechanisms.

Reviewer feedback on this answer:
This answer doesn't really address the specific question, but it does acknowledge that there might be a problem with the medical supply chain for TB during covid.  It does seem relevant.
This is a pretty good answer that talks about the WHO's focus on not running out of TB supplies during the pandemic and how they anticipate some delays in the supply chain.

Reviewer ratings:
Acceptable
Acceptable

Answer passage (source: WHO):
page_title: Q&A: Tuberculosis and COVID-19
section_headers: How can we protect people seeking tuberculosis care during the COVID-19 pandemic?
section_content: In a context of widespread restriction of movement of the population in
response to the pandemic and isolation of COVID-19 patients, communication
with the healthcare services should be maintained so that people with
tuberculosis (TB), especially those most vulnerable, get essential services.
This includes management of adverse drug reactions and co-morbidities,
nutritional and mental health support, and restocking of the supplies of
medicines.
Enough TB medicines will need to be dispensed to the patient or caregiver to
last until the next visit. This will limit interruption or unnecessary visits
to the clinic. Mechanisms to deliver medicines at home and even to collect
specimens for follow-up testing may become expedient. Home-based TB treatment
is bound to become more common. Alternative arrangements to reduce clinic
visits may involve limiting appointments to specific times to avoid exposure
to other clinic attendees; using digital technologies to maintain treatment
support. Community health workers become more critical as treatment is more
decentralized.
More TB patients will probably start their treatment at home and therefore
limiting the risk of household transmission of TB during the first few weeks
is important.
Vulnerable populations who have poor access to healthcare should not get
further marginalized during the pandemic.

Reviewer feedback on this answer:
This is a great response to a specific question about TB supplies. This goes into a lot of relevant detail that the person asking the question would want to know
This passage does talk about TB treatment, but it really doesn't say whether there is enough medical supplies with covid.

Reviewer ratings:
Excellent
Acceptable

Answer passage (source: WHO):
page_title: Q&A: Tuberculosis and COVID-19
section_headers: Are people with tuberculosis likely to be at increased risk of COVID-19 infection, illness and death?
section_content: While experience on COVID-19 infection in tuberculosis (TB) patients remains
limited, it is anticipated that people ill with both TB and COVID-19 may have
poorer treatment outcomes, especially if TB treatment is interrupted.
Older age, diabetes and chronic obstructive pulmonary disease (COPD) are
linked with more severe COVID-19 and are also risk factors for poor outcomes
in TB.
TB patients should take precautions as advised by health authorities to be
protected from COVID-19 and continue their TB treatment as prescribed.
People ill with COVID-19 and TB show similar symptoms such as cough, fever and
difficulty breathing. Both diseases attack primarily the lungs and although
both biological agents transmit mainly via close contact, the incubation
period from exposure to disease in TB is longer, often with a slow onset.

Reviewer feedback on this answer:
This is mostly talking about people with TB being at a higher risk while the question wants to know about potential TB shortage of supplies so this isn't really answering the question
This more talks about whether people with TB should continue taking their treatments with Covid.  The question isn't answered, but the information would be relevant.

Reviewer ratings:
Could be Improved
Could be Improved